BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35501497)

  • 21. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
    Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
    PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary undifferentiated pleomorphic sarcoma of the breast in a young female: a case report.
    Srinivasamurthy BC; Kulandaivelu AR; Saha K; Saha A
    World J Surg Oncol; 2016 Jul; 14(1):186. PubMed ID: 27421259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Undifferentiated Pleomorphic Sarcoma of the Distal Thigh: A Case Report.
    AlShaya OS; Alanazi SR; Alshaghathirah FM
    Cureus; 2024 Apr; 16(4):e58685. PubMed ID: 38774184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing.
    Zheng B; Qu Y; Wang J; Shi Y; Yan W
    Cancer Genomics Proteomics; 2019; 16(3):221-228. PubMed ID: 31018952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.
    Toulmonde M; Lucchesi C; Verbeke S; Crombe A; Adam J; Geneste D; Chaire V; Laroche-Clary A; Perret R; Bertucci F; Bertolo F; Bianchini L; Dadone-Montaudie B; Hembrough T; Sweet S; Kim YJ; Cecchi F; Le Loarer F; Italiano A
    EBioMedicine; 2020 Dec; 62():103131. PubMed ID: 33254023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PDGFRa amplification in multiple skin lesions of undifferentiated pleomorphic sarcoma: A clue for intimal sarcoma metastases.
    Osio A; Vignon-Pennamen MD; Pedeutour F; Le Maignan C; Koskas F; Lebbé C; Janin A; Battistella M
    J Cutan Pathol; 2017 May; 44(5):477-479. PubMed ID: 28105789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas.
    Serrano C; Romagosa C; Hernández-Losa J; Simonetti S; Valverde C; Moliné T; Somoza R; Pérez M; Vélez R; Vergés R; Domínguez R; Carles J; Ramón Y Cajal S
    Cancer; 2016 Jan; 122(1):99-107. PubMed ID: 26479291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome.
    Ono T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Akiyama T; Sugaya J; Fukushima S; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2022 Mar; 35(2):756-766. PubMed ID: 35118583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory Undifferentiated Pleomorphic Sarcoma Mimicking Bacteremia in an Elderly Patient: A Case Report.
    Hashimoto K; Nishimura S; Ito T; Oka N; Akagi M
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33670681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rare Case of Undifferentiated Pleomorphic Cardiac Sarcoma with Inflammatory Pattern.
    Stoica AI; Harpa MM; Banceu CM; Ghiragosian C; Opris CE; Al-Hussein H; Al-Hussein H; Flamind Oltean S; Mezei T; Mares RG; Suciu H
    Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 36013476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of PD-L1 Expression in Undifferentiated Pleomorphic Sarcomas, Liposarcomas and Chondrosarcomas.
    Zhang Y; Chen Y; Papakonstantinou A; Tsagkozis P; Linder-Stragliotto C; Haglund F
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of undifferentiated pleomorphic sarcoma of a retro-gastric origin, case report and review of literature.
    Almalki W; Alzahrani M; Alssaqqaf I; Baker B
    Int J Surg Case Rep; 2021 Dec; 89():106555. PubMed ID: 34839115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tislelizumab immunotherapy combined with chemotherapy in the treatment of a patient with primary anterior mediastinal undifferentiated pleomorphic sarcoma with high PD-L1 expression: A case report and literature review.
    Yang H; Qin Z; He X; Xue Q; Zhou H; Sun J; Li X; Zhao T
    Front Oncol; 2023; 13():1110997. PubMed ID: 37091183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rare case of undifferentiated pleomorphic sarcoma affecting the mandible - A case report.
    Mahapatra M; Panda A; Kumar H; Bhuyan L
    J Oral Maxillofac Pathol; 2024; 28(1):130-133. PubMed ID: 38800448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggressive undifferentiated pleomorphic sarcoma of the stomach involving long-term survival: A case report and literature review.
    Oguri Y; Cho H; Oohinata R; Onoyama H; Takada R; Motoi T
    Mol Clin Oncol; 2018 Dec; 9(6):661-665. PubMed ID: 30546898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth.
    Tokumoto H; Setoguchi T; Saitoh Y; Sasaki H; Nagano S; Maeda S; Tanimoto A; Taniguchi N
    Mol Carcinog; 2019 Dec; 58(12):2230-2240. PubMed ID: 31478563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary undifferentiated pleomorphic sarcoma in oral-maxillary area: retrospective study and molecular analysis.
    You Y; Shi R; Dai M; Du Z; Tian Z; Xu G; Wang L; Wang Y; Xiao M
    Histol Histopathol; 2021 Aug; 36(8):889-898. PubMed ID: 34282850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.